Evidence map›Paper›PMID 35566480›Full record

ArticleJournal of clinical medicine2022

Multiple Primary Melanomas: Retrospective Review in a Tertiary Care Hospital.

Rodolfo David Palacios-Diaz, Blanca de Unamuno-Bustos, Carlos Abril-Pérez, Mónica Pozuelo-Ruiz, Javier Sánchez-Arraez, Ignacio Torres-Navarro, Rafael Botella-Estrada

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Rodolfo David Palacios-DiazDepartment of Dermatology, Hospital Universitari i Politècnic La Fe, 46026 Valencia, Spain.ORCID 0000-0002-8353-7481
Blanca de Unamuno-BustosDepartment of Dermatology, Hospital Universitari i Politècnic La Fe, 46026 Valencia, Spain.
Carlos Abril-PérezDepartment of Dermatology, Hospital Universitari i Politècnic La Fe, 46026 Valencia, Spain.
Mónica Pozuelo-RuizDepartment of Dermatology, Hospital Universitari i Politècnic La Fe, 46026 Valencia, Spain.
Javier Sánchez-ArraezDepartment of Dermatology, Hospital Universitari i Politècnic La Fe, 46026 Valencia, Spain.
Ignacio Torres-NavarroDepartment of Dermatology, Hospital Universitari i Politècnic La Fe, 46026 Valencia, Spain.ORCID 0000-0002-5448-5360
Rafael Botella-EstradaDepartment of Dermatology, Hospital Universitari i Politècnic La Fe, 46026 Valencia, Spain.
Hospital Universitari i Politècnic La Fe · ESUniversitat de València · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multiple primary melanomas (MPM) refer to the occurrence of more than one synchronous or metachronous melanoma in the same individual. The aim of this study was to identify the frequency of MPM and describe the clinical and histopathologic characteristics of patients with MPM. An observational single-center retrospective study was designed based on a cohort of melanoma patients followed in a tertiary care hospital. Fifty-eight (8.9%) patients developed MPM. Most patients were men (65.5%) and the median age at the time of diagnosis of the first melanoma was 71 years old. The median time of diagnosis of the second melanoma from the first melanoma was 10.9 months, and 77.6% of second melanomas were diagnosed within the first 5 years. In total, 29 (50%) and 28 (48.3%) first and second melanomas were located in the trunk, respectively. Concordance of anatomic site between primary and subsequent melanoma was found in 46.6% of the patients. Proportion of in situ melanomas was increasingly higher in subsequent melanomas (from 36.21% of first melanomas to 100% of fifth melanomas). An increasing rate of melanomas with histological regression was observed within subsequent melanomas (from 60.3% of first melanomas to 80% of third melanomas). Our results support the importance of careful long-term follow-up with total body examination in melanoma patients.

Indexed as

follow-upfrequencymelanomamultiple primary melanomaregression

Identifiers

PMID35566480
PMCPMC9105033
OpenAlexW4224235379

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.